HomeTechnology

Technology

Uncategorized

Base to Base biotech podcast 75: AI-powered diagnostics and cancer immunotherapy

Jim Cornall - September 11, 2026

biotech

Is atherosclerosis an autoimmune disease?

Jim Cornall - September 10, 2026

biotech

Northway Biotech opens €61m cell therapy and personalised medicine CDMO in Lithuania

Jim Cornall - September 10, 2026

biotech

Eascra Biotech receives NASA contract for space-manufactured nanomedicine

Jim Cornall - September 10, 2026

Technology

Activate and The Engine to support deeptech entrepreneurs

Jim Cornall - December 20, 2024

Technology

New 3D concrete printing can capture CO2

Jim Cornall - December 19, 2024

Technology

New on-chip device uses exotic light rays in 2D material to detect molecules

Jim Cornall - November 22, 2024

Technology

EIF invests €28m for deeptech and technology transfer projects in Spain

Jim Cornall - November 20, 2024

financing

Iceland to Showcase tech startup scene at Slush 2024

Jim Cornall - November 19, 2024

Technology

Sabah Drone Open Day 2024 showcases technology and innovation

Jim Cornall - November 7, 2024

energy

New electromagnetic shielding material developed

Jim Cornall - November 1, 2024

energy

SiC power devices could transform industry

Jim Cornall - October 31, 2024

1 234...8 Page 3 of 8

Stay Connected

- Advertisement -

spot_img

Latest Articles

Uncategorized

Base to Base biotech podcast 75: AI-powered diagnostics and cancer immunotherapy

Jim Cornall - September 11, 2026 0

This week, we talk to a company in Lund, Asgard Therapeutics, and its co-founder and CEO Cristiana Pires, about in vivo direct cell reprogramming...

Is atherosclerosis an autoimmune disease?

biotech Jim Cornall - September 10, 2026 0

Northway Biotech opens €61m cell therapy and personalised medicine CDMO in Lithuania

biotech Jim Cornall - September 10, 2026 0

Eascra Biotech receives NASA contract for space-manufactured nanomedicine

biotech Jim Cornall - September 10, 2026 0

Typewriter Therapeutics emerges from stealth with $56m to pursue in vivo CAR T medicines

biotech Jim Cornall - September 9, 2026 0